3.40%
5.46%
-0.67%
-16.93%
-3.35%
-40.48%
20.30%
AI Spotlight on AVTR
Company Description
Avantor, Inc.provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.Avantor, Inc.
was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Market Data
| Last Price | 22.22 |
| Change Percentage | 3.40% |
| Open | 21.87 |
| Previous Close | 21.49 |
| Market Cap ( Millions) | 15123 |
| Volume | 3606373 |
| Year High | 28 |
| Year Low | 19.59 |
| M A 50 | 21.5 |
| M A 200 | 23.47 |
Financial Ratios
| FCF Yield | 4.94% |
| Dividend Yield | 0.00% |
| ROE | 5.74% |
| Debt / Equity | 88.62% |
| Net Debt / EBIDTA | 423.40% |
| Price To Book | 2.72 |
| Price Earnings Ratio | 48.83 |
| Price To FCF | 20.24 |
| Price To sales | 2.22 |
| EV / EBITDA | 18.05 |
News
- Jan -13 - MD vs. AVTR: Which Stock Is the Better Value Option?
- Jan -10 - Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
- Jan -03 - Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- Dec -18 - Avantor: Durable FCF Generator Trading For Cheap
- Dec -11 - MD or AVTR: Which Is the Better Value Stock Right Now?
- Nov -25 - MD or AVTR: Which Is the Better Value Stock Right Now?
- Nov -20 - Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
- Nov -20 - Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
- Nov -14 - Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
- Nov -07 - MD vs. AVTR: Which Stock Is the Better Value Option?
- Nov -06 - Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
- Oct -28 - Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
- Oct -25 - Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
- Oct -25 - Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- Oct -25 - Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
- Oct -25 - Avantor® Reports Third Quarter 2024 Results
- Oct -23 - Avantor® Strengthens Partnership with National Institute for Bioprocessing Research and Training (NIBRT) to Address Critical Biopharma Industry Challenges
- Oct -21 - AVTR Stock Flat Following the Close of Divestiture Deal With Audax
- Oct -18 - Audax Private Equity Completes Carveout of Avantor, Inc.'s Clinical Services Business and Rebrands the Company as Resonant Clinical Solutions
- Oct -18 - Avantor® Closes Previously Announced Divestiture of its Clinical Services Business
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Proprietary Materials & Consumables
Expected Growth : 5 %
What the company do ?
Avantor's Proprietary Materials & Consumables offer high-quality, specialized products for life sciences, advanced technologies, and applied materials, enhancing research and production efficiency.
Why we expect these perspectives ?
Avantor's Proprietary Materials & Consumables segment growth is driven by increasing demand for bioprocessing and pharmaceutical production, expansion into emerging markets, and strategic acquisitions. Additionally, the company's focus on innovation and R&D investments in high-growth areas such as gene therapy and mRNA-based vaccines contributes to its 5% growth rate.
Segment n°2 -> Third Party Materials & Consumables
Expected Growth : 3 %
What the company do ?
Third Party Materials & Consumables from Avantor, Inc. refers to laboratory supplies and materials sourced from external partners, offering a broad range of products for research and production.
Why we expect these perspectives ?
Avantor's Third Party Materials & Consumables segment growth is driven by increasing demand for bioprocessing and pharmaceutical production, expansion into emerging markets, and strategic partnerships. Additionally, the company's ability to provide high-quality, cost-effective solutions and its strong relationships with suppliers contribute to its growth.
Segment n°3 -> Services & Specialty Procurement
Expected Growth : 4 %
What the company do ?
Avantor's Services & Specialty Procurement provides customized procurement solutions for life sciences, advanced technologies, and applied materials, offering tailored sourcing and supply chain management.
Why we expect these perspectives ?
Avantor's Services & Specialty Procurement segment growth is driven by increasing demand for bioprocessing and pharmaceutical development, expansion of research and development activities, and strategic partnerships. Additionally, the company's investments in digital platforms and e-commerce capabilities enhance customer experience, leading to increased adoption and retention.
Segment n°4 -> Equipment & Instrumentation
Expected Growth : 3 %
What the company do ?
Avantor's Equipment & Instrumentation provides a wide range of innovative and high-quality laboratory equipment and instruments for various industries and applications.
Why we expect these perspectives ?
Avantor's Equipment & Instrumentation segment growth is driven by increasing demand for bioprocessing and research applications, expansion in emerging markets, and strategic acquisitions. Additionally, the segment benefits from the company's strong relationships with pharmaceutical and biotechnology customers, as well as its ability to provide customized solutions and services.
Avantor, Inc. Products
| Product Range | What is it ? |
|---|---|
| Biotechnology Products | Avantor offers a range of biotechnology products, including nucleic acid purification kits, PCR reagents, and molecular biology enzymes. |
| Chemicals and Reagents | Avantor provides a wide range of chemicals and reagents, including organic and inorganic compounds, solvents, and biochemicals. |
| Lab Supplies and Equipment | Avantor offers a variety of lab supplies and equipment, including pipettes, tubes, and laboratory instruments. |
| Pharmaceutical Ingredients | Avantor provides active pharmaceutical ingredients (APIs) and excipients for the development and manufacturing of pharmaceutical products. |
| Custom Manufacturing Services | Avantor offers custom manufacturing services, including contract manufacturing, toll manufacturing, and private labeling. |
| Research and Development Services | Avantor provides research and development services, including process development, scale-up, and analytical services. |
Avantor, Inc.'s Porter Forces
Threat Of Substitutes
Avantor, Inc. operates in a niche market with limited substitutes, but the threat of substitutes is still present due to the availability of alternative products and services.
Bargaining Power Of Customers
Avantor, Inc. has a diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products and services are critical to its customers' operations, making it difficult for customers to negotiate prices.
Bargaining Power Of Suppliers
Avantor, Inc. relies on a few large suppliers for certain raw materials, which gives these suppliers some bargaining power. However, the company's diversified supply chain and long-term contracts mitigate this risk.
Threat Of New Entrants
The biotechnology and pharmaceutical industries have high barriers to entry, including significant capital requirements, regulatory hurdles, and the need for specialized expertise. This limits the threat of new entrants.
Intensity Of Rivalry
The biotechnology and pharmaceutical industries are highly competitive, with many established players and new entrants vying for market share. Avantor, Inc. faces intense competition from companies with similar product offerings and strong research and development capabilities.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 51.32% |
| Debt Cost | 6.58% |
| Equity Weight | 48.68% |
| Equity Cost | 10.76% |
| WACC | 8.61% |
| Leverage | 105.41% |
Avantor, Inc. : Quality Control
Avantor, Inc. passed 2 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| WDFC | WD-40 Company develops and sells maintenance products, and homecare and cleaning products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides multi-purpose maintenance products … |
| AVNT | Avient Corporation provides specialized formulator, services, and sustainable material solutions in the United States, Canada, Mexico, Europe, South America, and Asia. It operates through three segments: Color, Additives and Inks; … |
| KWR | Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications. The company operates through four segments: Americas; Europe, Middle … |
| AXTA | Axalta Coating Systems Ltd., through its subsidiaries, manufactures, markets, and distributes high-performance coatings systems in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It operates … |
| ALB | Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Avient
A-Score
1-Year Total Return ->
🥈
Albemarle
A-Score
1-Year Total Return ->
🥉
Axalta Coating Systems
A-Score
1-Year Total Return ->
4
Avantor
A-Score
1-Year Total Return ->
5
WD-40
A-Score
1-Year Total Return ->
6
